Panel discussion: Improving the pathway of lung cancer patients, can we do it better?
A. Šajnic (Zagreb, Croatia), T. Blum (Berlin, Germany), Prof. Marko Jakopovic (Zagreb, Croatia), A. Breški (Zagreb, Croatia), I. Belina (Zagreb, Croatia), G. Hardavella (Athens, Greece), M. J. Catarata (Porto, Portugal)
Thursday, 16 December 2021 |   |
Translational perspectives in paediatric OSA: Guts and particles lead the way!
D. Gozal (Columbia, USA), R. Ersu (Ottawa, Canada)
Tuesday, 30November 2021 | |
Panel discussion: COVID-19 – Looking into the Future
A. Simonds (London, United Kingdom), G. C. Khilnani (New Delhi, India), J. Chalmers (Dundee, United Kingdom), D. J. Christopher (Vellore, India), S. Joshi (India)
Tuesday, 30 November 2021 | |
Debate – Controversies in interstitial lung disease
M. Kreuter (Heidelberg, Germany), K. Antoniou (Heraklion, Greece), C. Ravaglia (Forli, Italy), A. Tzouvelekis (Athens, Greece), D. Culver (Cleveland, United States of America), A. Vorselaars (Nieuwegein, Netherlands)
Tuesday, 09 November 2021
Access for REGISTERED non-members
|  |
COVID-19 vaccination and more
A. Yorgancioglu (Konak, Turkey), J. Chorostowska (Warsaw, Poland), T. Welte (Hannover, Germany), M. Akova (Ankara, Turkey), A. Sayiner (Izmir, Turkey)
Thursday, 05 November 2021 | |
Occupational dust induced lung diseases
R. Cohen (River Forest, USA), E. Fireman (Tel-Aviv, Israel)
Tuesday, 19 October 2021 | |
Immunotherapy in severe asthma
A. Bossios (Stockholm, Sweden), W. Canonica (Milan, Italy), C. Porsbjerg (Copenhagen, Denmark)
Tuesday, 05 October 2021 | |
Occupational COVID-19
R. E. de la Hoz (New York, USA), K. Fennelly (Bethesda, USA)
Thursday, 30 September 2021 | |
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
M. Guckenberger (Zürich, Switzerland), T. De Baere (Paris, France), E. Pompeo (, Italy) N. N. Valentin (Salamanca, Spain),
Tuesday, 21 September 2021 | |
TB and COVID-19 – a dangerous new combination?
Giovanni Battista Migliori (Varese (VA), Italy), Alberto García-Basteiro (Maputo, Mozambique)
Thursday, 22 July 2021 | |
Challenges in the management of SCLC Part 2: Extensive disease, prophylaxis/treatment of brain metastases
T. Blum (Berlin, Germany), J. Cadranel (Paris, France), D. Jovanovic (Belgrade, Serbia)
Wednesday, 14 July 2021 | |
Air pollution and the lung in children: the evidence for exposure and prevention measures
R. Naidoo (PATS), I. de Kleer (ERS), R. Nantanda (Uganda), J. Usemann (Switzerland)
Tuesday, 13 July 2021 | |
Sleep; throughout the pandemic and beyond
M. Bonsignore (Palermo, Italy), J. Steier (London, United Kingdom), S. Schiza (Heraklion, Greece), W. Randerath (Solingen, Germany)
Monday, 12 July 2021 | |
ERS statement on Philips devices: clinicians’ and patients’ perspectives, and questions to be answered
A. Simonds (London, England), W. Randerath (Solingen, Germany), R. Ersu (Ottawa, Canada), J. C. Winck (Vila Nova de Gaia, Portugal), M. Duiverman (Groningen, Netherlands), S. Schiza (Heraklion, Greece), L. Roberti (ELF, Rome, Italy)
Thursday, 01 July 2021 | |
ERS guidelines on treatment of sarcoidosis
D. Valeyre (Paris, France), Robert P. Baughman (Cincinnati, USA), P. Korsten (Göttingen, Germany)
Wednesday, 23 June 2021 | |
Excerpts from the upcoming ERS Monograph on COVID-19
L. Lui (Toronto, Canada), A. Simonds (London, United Kingdom), F. Amati (Milan, Italy), A. Fabre (Dublin, Ireland), S. Ramjug (Manchester, United Kingdom)
Tuesday, 15 June 2021 | |
Respiratory medicine meets rheumatology: What is new in connective tissue diseases – ILD
E. Bargagli, (Siena, Italy), E. Renzoni (London, United Kingdom), O. Distler (Zurich, Switzerland), K. Antoniou (Heraklion, Greece), B. Crestani (Paris, France)
Monday, 14 June 2021 | |
Neuroendocrine tumours of the lung other than SCLC
A.M. Dingemans(Rotterdam, Netherlands), J. Derks (Maastricht, Netherlands)
Tuesday, 8 June 2021 | |
Evidence-based eHealth for COPD
N. Chavannes (Leiden, Netherlands), M. Vitacca (Brescia, Italy), V. Poberezhets (Vinnytsia, Ukraine)
Thursday, 27 May 2021 | |
Physical activity as an outcome measure or as a way to provide feedback to patients. How should it be assessed, analysed and interpreted?
H. Demeyer (Leuven, Belgium), A. Nyberg (Umeå, Sweden)
Tuesday, 25 May 2021 | |
Challenges in the management of SCLC
T. Blum (Berlin, Germany), J. Cadranel (Paris, France), D. Jovanovic (Belgrade, Serbia)
Tuesday, 18 May 2021 | |
ERS practice guidelines for the diagnosis of asthma in children aged 5 to 16 years
A. Moeller (Zurich, Switzerland), E. Gaillard (Leicester, United Kingdom)
Thursday, 22 April 2021 | |
PATS and ERS paediatric webinar: reducing the burden of CAP
A. Irungu (PATS, Nairobi, Kenya), Stefan Unger (Edinburgh, United Kingdom), A. Goga (Pretoria, South Africa), Massimiliano Don (Udine, Italy)
Thursday, 15 April 2021 | |
Lung diseases and self-management – what is missing?
M. Clari (Torino, Italy), J. De Brandt (Diepenbeek, Belgium), C. Kelly (Lancashire, UK), K. Heslop-Marshall (Newcastle upon Tyne, UK), S. Jones (Cambridge, United Kingdom)
Tuesday, 13 April 2021 | |
Congenital airway diseases
Eber (Graz, Austria), M. Schnater (Rotterdam, Netherlands), L. S. J. Kamphuis (Rotterdam, Netherlands), M. W.H. Pijnenburg (Rotterdam, Netherlands), C. Gotera (Madrid, Spain)
Tuesday, 23 March 2021 | |
ERS statement on chronic thromboembolic pulmonary hypertension
M. Delcroix (Leuven, Belgium), G. Simonneau (Le Kremlin-Bicêtre, France), E. Mayer (Bad Nauheim, Germany)
Thursday, 18 March 2021 | |
ERS short guidelines on COVID-19 management
N. Roche (Paris, France), J. Chalmers (Dundee, United Kingdom)
Thursday, 4 March 2021 | |
Wearable technologies in respiratory functional assessment
I. Vogiatzis (Newcastle upon Tyne, United Kingdom), A. Aliverti (Milan, Italy)
Thursday, 25 February 2021 |  |
Lung functional imaging
S. Bayat (Grenobe, France), G. Parraga (London (ON), Canada), J. M. Wild (Sheffield (South Yorkshire), United Kingdom)
Thursday, 11 February 2021 | |
ERS clinical practice guidelines on bronchiectasis in children
A. Chang (Australia), A. Kantar (Italy)
Tuesday, 2 February 2021 | |
Understanding new vaccines for SARS-CoV-2 and their regulation
A. Simonds (London, United Kingdom), T. Welte (Hannover, Germany), M. Cavaleri (Amsterdam, Netherlands), R. Boyton (London, United Kingdom)
Monday, 1 February 2021 | |
ERS guideline on withdrawal of inhaled corticosteroids in COPD
J. Chalmers (Dundee, United Kingdom), M. Miravitlles (Barcelona, Spain)
Thursday, 21 January 2021 | |
IGRAs and other TB infection tests
D. Goletti (Rome, Italy), R. Duarte (Porto, Portugal)
Tuesday, 12 January 2021 | |